Cargando…

Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study

Detalles Bibliográficos
Autores principales:	Takuva, Simbarashe, Takalani, Azwidhwi, Garrett, Nigel, Goga, Ameena, Peter, Jonny, Louw, Vernon, Opie, Jessica, Jacobson, Barry, Sanne, Ian, Gail-Bekker, Linda, Gray, Glenda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190951/ https://www.ncbi.nlm.nih.gov/pubmed/34077639 http://dx.doi.org/10.1056/NEJMc2107920

Ejemplares similares

Allergic reactions to the Ad26.COV2.S vaccine in South Africa
por: Peter, Jonny, et al.
Publicado: (2021)

Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)
por: Jacobson, Barry Frank, et al.
Publicado: (2023)

Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial
por: Takuva, Simbarashe, et al.
Publicado: (2022)

Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa
por: Gray, Glenda, et al.
Publicado: (2022)

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study
por: Bekker, Linda-Gail, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
por: Goga, Ameena, et al.
Publicado: (2022)

Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2023)

Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection
por: Moyo-Gwete, Thandeka, et al.
Publicado: (2023)

Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells
por: Krause, Robert G. E., et al.
Publicado: (2023)

Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner
por: Keeton, Roanne, et al.
Publicado: (2021)

High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron
por: Garrett, Nigel, et al.
Publicado: (2022)

Review of preventative HIV vaccine clinical trials in South Africa
por: Laher, Fatima, et al.
Publicado: (2020)

Poor CD4 recovery and risk of subsequent progression to AIDS or death despite viral suppression in a South African cohort
por: Takuva, Simbarashe, et al.
Publicado: (2014)

Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010
por: Ndlovu, Zibusiso, et al.
Publicado: (2014)

Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making
por: Sebilo, Motlalepula, et al.
Publicado: (2021)

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
por: Magaret, Craig, et al.
Publicado: (2023)

Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
por: Takuva, Simbarashe, et al.
Publicado: (2013)

High Asymptomatic Carriage With the Omicron Variant in South Africa
por: Garrett, Nigel, et al.
Publicado: (2022)

Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV)
por: Khan, Khadija, et al.
Publicado: (2021)

Hope for HIV control in southern Africa: The continued quest for a vaccine
por: Bekker, Linda-Gail, et al.
Publicado: (2017)

Impact of Preexisting Anti–Adenovirus 26 Humoral Immunity on Immunogenicity of the Ad26.COV2.S Coronavirus Disease 2019 Vaccine( )
por: Le Gars, Mathieu, et al.
Publicado: (2022)

Comparative durability of nevirapine versus efavirenz in first-line regimens during the first year of initiating antiretroviral therapy among Swaziland HIV-infected adults
por: Takuva, Simbarashe, et al.
Publicado: (2013)

Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa
por: Miot, Jacqui, et al.
Publicado: (2021)

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses
por: Hopkins, Kathryn L., et al.
Publicado: (2014)

In memoriam: Gita Ramjee
por: Bekker, Linda‐Gail, et al.
Publicado: (2020)

Moving towards elimination: findings from the South Africa prevention of mother to child transmission evaluation (SAPMTCTE)
por: Kuhn, Louise, et al.
Publicado: (2019)

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa
por: Collie, Shirley, et al.
Publicado: (2021)

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S
por: Sadoff, Jerald, et al.
Publicado: (2022)

Ethically acceptable consent approaches to adolescent research in South Africa
por: Loveday, Marian, et al.
Publicado: (2022)

Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern
por: Kitchin, Dale, et al.
Publicado: (2022)

Global challenges with scale-up of the integrated management of childhood illness strategy: results of a multi-country survey
por: Goga, Ameena E, et al.
Publicado: (2011)

Completeness of the Road-to-Health Booklet and Road-to-Health Card: Results of cross-sectional surveillance at a provincial tertiary hospital
por: Naidoo, Harishia, et al.
Publicado: (2018)

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa
por: Collie, Shirley, et al.
Publicado: (2022)

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
por: Sadoff, Jerald, et al.
Publicado: (2021)

‘We are the advocates for the babies’ - understanding interactions between patients and health care providers during the prevention of mother-to-child transmission of HIV in South Africa: a qualitative study
por: Heerink, Fiona, et al.
Publicado: (2019)

Trends and predictors of mother-to-child transmission of HIV in an era of protocol changes: Findings from two large health facilities in North East Nigeria
por: Itiola, Ademola Joshua, et al.
Publicado: (2019)

AD#20 (26.08.98) Compte rendu
por: Buttkus, J
Publicado: (1998)

AD#26 (17.08.99) compte rendu
Publicado: (1999)

Ad26.cov2-s: Myocarditis: case report
Publicado: (2021)

Ad26.cov2-s: Rhabdomyolysis: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h4fh0o7ias6q92tnsfah17dkb5